JW 67

Research use only, not for human use.

JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.

JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.(In Vitro):JW 67 inhibits the canonical Wnt signaling with an IC50 of 1.17μM. JW 67 (1 μM) increased concentration of AXIN2 and decreased the active form of β-catenin. JW 67 (10 or 25μM) reduced growth of SW480 CRC cells in vitro by inhibiting cell-cycle progression at the G1/S.

JW67 (1 μM; 24 hours) increases concentration of AXIN2 and decreases the active form of β-catenin.JW67 affects the expression of Wnt target genes and reduces cell growth of colon cancer cell lines.JW67 shows a concentration dependent reduction in proliferation with a GI50 value of 7.8 μM. Western Blot Analysis Cell Line:SW480 cells Concentration:1 μM Incubation Time:24 hours Result:Increased the AXIN2 expression.RT-PCR Cell Line:SW480 cells Concentration:10 or 25μM Incubation Time:72 hours Result:Reduced growth of SW480 CRC cells in vitro by inhibiting cell-cycle progression at the G1/S.

——

JW67

Wnt/Notch/Hedgehog

Wnt/beta/catenin

——

——

——

442644-28-2

394.383

C21H18N2O6

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (126.78 mM)

O=C1Nc2ccccc2C11OCC2(CO1)COC1(OC2)C(=O)Nc2ccccc12

——

(-20℃)

With Ice Pack

≥ 2 years